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Abstract
Schmidt syndrome (PGA syndrome type II) is a rare condition characterized by polyglandular 
failure. It is an autosomal dominant trait with variable expressivity that was inherited over four 
generations in an Indiana kindred. Association of HLA-B8 has been reported with Schmidt 
syndrome. Our proband is a 12-year-old boy with Addison disease, insulin dependent diabetes 
mellitus (IDDM), and vitiligo. Two of his eight sibs had either IDDM (sister) or vitiligo and 
hyperthyroidism (brother). His mother had hypothyroidism. Seven members of earlier generations 
apparently were also affected. We obtained peripheral blood for HLA and genetic analysis from 21 
relatives in a family with 8 Schmidt syndrome individuals in three generations. HLA studies on 15 
affected and unaffected relatives showed only 2 of 7 persons with B8-containing haplotypes. 
Therefore, no association exists between the B8-containing haplotype and the syndrome.
We identified informative marker loci. No evidence for linkage of the Schmidt locus to any of the 
14 markers was found and close linkage to esterase D and adenylate kinase and possibly properdin 
factor B was excluded.
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Introduction
After Schmidt [1926] described two patients with nontuberculous Addison disease and 
chronic lymphocytic thyroiditis, the association of these two disorders was increasingly 
recognized. Carpenter et al [1964] reviewed the condition and added 15 new cases. Several 
of these individuals also had diabetes mellitus. By 1981, it was clear that the condition 
described by Schmidt was autoimmune in nature, involved several endocrine glands 
(adrenal, thyroid, pancreas, gonads) and other tissues, and could be divided into three types 
[Neufeld et al, 1980, 1981]: PGA (polyglandular autoimmune syndrome) type I, 
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characterized by Addison disease, hypoparathyroidism, and chronic mucocutaneous 
candidiasis with alopecia, malabsorption syndrome, gonadal failure, pernicious anemia, and 
chronic active hepatitis as decreasingly frequent concomitants; PGA syndrome type II: 
Addison disease, autoimmune thyroid disease (69%), insulin-requiring diabetes mellitus 
(52%), and neither hypoparathyroidism nor chronic mucocutaneous candidiasis; and, PGA 
syndrome type III in which Addison disease is absent but autoimmune thyroid disease is 
accompanied by another autoimmune dysfunction.
Several additional characteristics of PGA syndrome type II deserve note. The adrenal failure 
generally appears after 10 years and the peak age-of-onset is between 20–40 years. A 
number of authors [Thomsen et al, 1975; Eisenbarth et al, 1978, 1979; Neufeld et al, 1981] 
noted striking increases of HLA-A1 and HLA-B8 antigens in some patients, whereas others 
[Anderson et al, 1980] did not find the HLA association. Only four families of individuals 
with PGA syndrome type II have been published [Eisenbarth et al, 1978, 1979; Anderson et 
al, 1980; Farid et al, 1980]. We report here a large kindred with apparent autosomal 
dominant inheritance of PGA syndrome type II, the first report of a family with clear 
evidence of this mode of transmission.
Methods
Patients
Patient 1, the propositus, was 10 4/12 years old when first seen. He developed asthma and 
nephrotic syndrome characterized by edema and proteinuria at 5 years, insulin dependent 
diabetes mellitus at 6 years and vitiligo at 9 years. At that time he began to have frequent 
insulin reactions and a decreased insulin requirement. At 10 years he had “flu” and shortly 
afterwards was admitted because of dizziness, nausea, and vomiting. His blood pressure and 
urine output decreased and he became unresponsive. Hyponatremia and hyperkalemia were 
found and the diagnosis of Addison disease was made. He was then transferred to our 
medical center. Treatment included NPH InsulinR, FlorinefR, and CortefR.
Physical examination showed a well-built, muscular, 10-year-old boy with height and weight 
at the 50th percentile. There was a hypopigmented area above the right eyelid and 
hypopigmented areas were seen on the fingertips and toes. The rest of the skin was bronzed 
with pigmented dermal creases and there was a cafe-au-lait spot on the right thigh. There 
was a short uvula and increased carrying angle of the arms.
Patient 2 (IV-6) is the 20-year-old sister of the propositus. She has had diabetes mellitus 
since age 3 years and reportedly had kidney infections. She was pregnant at the time of 
examination.
Patient 3 (IV-9) is the 16-year-old brother of the propositus. He has had hyperthyroidism 
from age 10 years and hypopigmentation of the legs and arms since age 3 years. He has no 
signs of hyperpigmentation at present.
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Patient 4 (III-11) is the propositus' mother. She is 44 years old and has been receiving 
medication for hypothyroidism of unknown etiology for the past 7 years. She is normal 
physically and is asymptomatic.
Patient 5 (II-5) is the propositus' maternal grandfather. He had vitiligo since childhood and 
died from a “stroke.” There was no history of other endocrine failure.
Patient 6 (II-3) is the propositus' maternal great aunt. She is 71 years old and has had 
hypopigmentation of the legs, feet, hands and abdomen since age 7 years and noninsulin 
dependent diabetes mellitus for the past 10 years. She also has asthma but no other signs of 
endocrine failure.
Patient 7 (II-10) is the propositus' maternal great aunt. She is 61 years old and has had 
hypopigmentation of the legs, arms, hands and upper torso since age 29 years and has been 
receiving medication for pernicious anemia for the past 6 years. She also has asthma and 
arthritis but no other signs of endocrine failure.
Patient 8 (II-12) is the propositus' maternal great aunt. She is 56 years old and has had 
hypopigmentation of the hands for the past year. She has been receiving medication for 
hypothyroidism of unknown etiology since age 38 years. She had asthma as a child but no 
other signs of endocrine failure.
Patient 9 (III-19) is patient 8′s son. He is 29 years old and has had hypopigmentation of the 
hands since age 26 years. He has gastric ulcers but no other physical abnormalities.
Other relatives and their disorders are shown in Figure 1. The proband's maternal great 
grandfather and great great aunt had pernicious anemia but no other physical abnormalities; 
therefore the Schmidt syndrome gene was inherited from the grandfather in this family. 
Several family members at risk for Schmidt syndrome have only noninsulin dependent 
diabetes mellitus and were not considered to have Schmidt syndrome. All other relatives 
were considered normal.
Linkage Analysis
We typed 21 individuals, including 8 with Schmidt syndrome, in three generations for 17 
marker loci and HLA-A, B, and C in an attempt to localize the gene. Four of these loci, Kell, 
ACPI, ADA and GC were not informative for linkage. The remaining 14 loci were analyzed 
for linkage using the computer program LIPED [Ott, 1974]. Inspection of the family 
suggested an approximate penetrance of 70%, which was included in the linkage analysis. 
The markers, chromosomes on which they reside, and lod scores at different recombination 
fractions are shown in Table I.
Results
There is no evidence for linkage of the Schmidt locus to any of the 14 informative markers; 
a lod score less than −2.0 is taken as sufficient evidence for rejecting the hypothesis of 
linkage [Morton, 1955]. Linkage to esterase D (ESD) and adenylate kinase (AK) can be 
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rejected at a recombination fraction of 5% or less. Linkage to properdin factor B (BF) is 
close to rejection at a recombination fraction of 5% or less.
Because of the reported association of HLA and the Schmidt syndrome, it is of interest to 
note the lod scores for HLA as well as other markers on chromosome 6. The highest lod 
score for HLA was 0.15 at 30% recombination fraction and the lowest lod score was −0.42 
at 5% recombination. This evidence does not support linkage to HLA; however, we cannot 
exclude this marker with a lod score of −0.42.
Discussion
The polyglandular autoimmune disorders are now well characterized. Our proband fits well 
into the PGA syndrome type II classification of Neufeld et al [1980, 1981] although he has 
not (yet) developed thyroid disease. His mother and a sib do have thyroid involvement and 
other relatives have one or more manifestations of PGA syndrome type II. The proband 
probably first showed manifestations of the disease at age 6 years but other relatives had 
variable ages of onset between childhood and 38 years. The variability in age of onset and 
expressivity has been noted by others [Eisenbarth and Lebovitz, 1978; Eisenbarth et al, 
1978, 1979; Anderson et al, 1980; Farid et al, 1980; Wirfalt, 1981].
HLA association has been reported for PGA II but not for PGA I. Eisenbarth et al [1978, 
1979] found a close association with HLA-A1 and HLA-B8. Farid et al [1980] found this 
association to hold in some but not all families. The family reported on by Anderson et al 
[1980] and our family failed to show such association.
The size (N = 37) and cooperativeness of our family permitted us to seek linkage of PGA 
syndrome type II with other markers. This led to exclusion of AK and ESD and possibly BF 
at close linkage, and no evidence for linkage was found with HLA or 13 other informative 
markers.
The inheritance of PGA syndrome type II, and indeed the other PGA syndromes, has been 
unclear. Various modes of inheritance of PGA syndromes have been suggested. Confusion in 
genetic analysis may have resulted from the confounding of the various PGA syndrome 
types. In our family, inheritance is clearly autosomal dominant type with reduced 
penetrance, variable expressivity and male-to-male transmission (Fig. 1). The family of 
Anderson et al [1980] suggested polygenic determination although nonpenetrance in the 
common father may have been responsible for the inheritance pattern.
We think that PGA syndrome type II, which is segregating in our family, may itself be 
heterogeneous in origin. Families such as the one presented here represent autosomal 
dominant inheritance and reduced penetrance and no association with specific HLA-A or B 
haplotypes.
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Fig. 1. 
Pedigree of Schmidt syndrome family. Examination of the individual indicated by a bar over 
the symbol denoting the case. The HLA A and B haplotypes, e.g. (A2,B5)/(A2,B18) are 
indicated under the symbols for male (□) or female (○). □, Ø male, female (deceased).
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